<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40591429</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1853-0605</ISSN><JournalIssue CitedMedium="Internet"><Volume>82</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Jun</Month><Day>26</Day></PubDate></JournalIssue><Title>Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)</Title><ISOAbbreviation>Rev Fac Cien Med Univ Nac Cordoba</ISOAbbreviation></Journal><ArticleTitle>[Renal cell carcinoma metastasis to the thyroid gland after drug-induced thyroid dysfunction: case report].</ArticleTitle><Pagination><StartPage>419</StartPage><EndPage>430</EndPage><MedlinePgn>419-430</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.31053/1853.0605.v82.n2.45462</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Renal cell carcinoma may be associated with highly aggressive behavior and metastatic disease may be present in 30% of patients at the time of diagnosis. The most common sites of metastasis are the lungs, regional lymph nodes, liver, and bones. Metastases at rare sites include gums, larynx, nasal cavity, and thyroid gland. The objective of this article is to report an unusual manifestation of a known disease and present emerging technology useful in patient management.</AbstractText><AbstractText Label="CLINICAL CASE">A 60-year-old male patient with a history of renal cell carcinoma. He initially received onco-specific treatment with nephrectomy and, ten years later, with zoledronate, pazopanib, and nivolumab due to metastatic progression. Four months after starting systemic treatment, drug-induced thyroid dysfunction was diagnosed, manifested by fatigue and abnormal laboratory results (TSH 9,23 uUI/mL). Due to the sensation of a lump in the neck, an ultrasound revealed a thyroid nodule on the right side. Aided by doppler ultrasound, and strain elastography, an ultrasound guided fine-needle aspiration biopsy of the thyroid nodule was performed, which confirmed metastasis of renal cell carcinoma.</AbstractText><AbstractText Label="CONCLUSION">The emergence of a thyroid nodule in patients with a history of renal cell carcinoma and thyroid dysfunction could indicate oncological progression, even a long time after the initial diagnosis.</AbstractText><CopyrightInformation>Universidad Nacional de C&#xf3;rdoba</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Del Valle</LastName><ForeName>Juan Bautista</ForeName><Initials>JB</Initials><Identifier Source="ORCID">0000-0002-5348-4681</Identifier><AffiliationInfo><Affiliation>Hospital Italiano de Buenos Aires.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roa Garcia</LastName><ForeName>Julio Cesar</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Hospital Italiano de Buenos Aires.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osorio Monta&#xf1;o</LastName><ForeName>Mauricio Arturo</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0009-0004-2721-4364</Identifier><AffiliationInfo><Affiliation>Hospital Italiano de Buenos Aires.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Echavarria Cadena</LastName><ForeName>Cristian Andres</ForeName><Initials>CA</Initials><Identifier Source="ORCID">0000-0002-6291-2051</Identifier><AffiliationInfo><Affiliation>Hospital Italiano de Buenos Aires.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savluk</LastName><ForeName>Jesica Lorena</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0002-9939-8260</Identifier><AffiliationInfo><Affiliation>Hospital Italiano de Buenos Aires.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borensztein</LastName><ForeName>Mat&#xed;as Adri&#xe1;n</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0003-3302-8985</Identifier><AffiliationInfo><Affiliation>Hospital Italiano de Buenos Aires.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType></PublicationTypeList><VernacularTitle>Met&#xe1;stasis de carcinoma de c&#xe9;lulas renales a la gl&#xe1;ndula tiroides tras disfunci&#xf3;n tiroidea medicamentosa: reporte de un caso.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Argentina</Country><MedlineTA>Rev Fac Cien Med Univ Nac Cordoba</MedlineTA><NlmUniqueID>8303003</NlmUniqueID><ISSNLinking>0014-6722</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007191">Indazoles</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002292" MajorTopicYN="Y">Carcinoma, Renal Cell</DescriptorName><QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007680" MajorTopicYN="Y">Kidney Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013964" MajorTopicYN="Y">Thyroid Neoplasms</DescriptorName><QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007191" MajorTopicYN="N">Indazoles</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="OBJETIVO">El carcinoma de c&#xe9;lulas renales puede estar asociado a un comportamiento altamente agresivo y la enfermedad metast&#xe1;sica puede estar presente en el 30% de los pacientes en el momento del diagn&#xf3;stico. Los sitios m&#xe1;s comunes de met&#xe1;stasis son los pulmones, ganglios linf&#xe1;ticos regionales, h&#xed;gado y huesos. Las met&#xe1;stasis en sitios raros incluyen enc&#xed;as, laringe, cavidad nasal y gl&#xe1;ndula tiroides. El objetivo de este art&#xed;culo es reportar una manifestaci&#xf3;n inusual de una enfermedad conocida y presentar tecnolog&#xed;a emergente &#xfa;til en el manejo del paciente.</AbstractText><AbstractText Label="CASO CL&#xcd;NICO">Paciente masculino de 60 a&#xf1;os, con antecedentes de carcinoma de c&#xe9;lulas renales. Recibi&#xf3; tratamiento onco-espec&#xed;fico inicial con nefrectom&#xed;a y, diez a&#xf1;os despu&#xe9;s, con zoledronato, Pazopanib y Nivolumab debido a progresi&#xf3;n metast&#xe1;sica. Cuatro meses despu&#xe9;s de iniciar el tratamiento sist&#xe9;mico, se diagnostic&#xf3; disfunci&#xf3;n tiroidea inducida por medicamentos, manifestada por fatiga y resultados anormales en pruebas de laboratorio (TSH 9.23 uUI/mL). Debido a la sensaci&#xf3;n de un bulto en el cuello, una ecograf&#xed;a revel&#xf3; un n&#xf3;dulo tiroideo en el lado derecho. Mediante ecograf&#xed;a, doppler y elastograf&#xed;a por compresi&#xf3;n se ejecut&#xf3; punci&#xf3;n biopsia de con aguja fina de n&#xf3;dulo tiroideo que certific&#xf3; met&#xe1;stasis de c&#xe1;ncer de c&#xe9;lulas renales.</AbstractText><AbstractText Label="CONCLUSI&#xd3;N">La aparici&#xf3;n de un n&#xf3;dulo tiroideo de reciente desarrollo en pacientes con antecedentes de carcinoma de c&#xe9;lulas renales y disfunci&#xf3;n tiroidea podr&#xed;a indicar la progresi&#xf3;n oncol&#xf3;gica, incluso mucho tiempo despu&#xe9;s del diagn&#xf3;stico inicial.</AbstractText><CopyrightInformation>Universidad Nacional de C&#xf3;rdoba</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">recurrence</Keyword><Keyword MajorTopicYN="N">carcinoma, renal cell</Keyword><Keyword MajorTopicYN="N">biopsy, needle</Keyword><Keyword MajorTopicYN="N">thyroid gland</Keyword><Keyword MajorTopicYN="N">elasticity imaging techniques</Keyword><Keyword MajorTopicYN="N">ultrasonography</Keyword></KeywordList><CoiStatement>
<b>Conflicto de inter&#xe9;s:</b>
 Ninguno.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>1</Day><Hour>21</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>1</Day><Hour>21</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>1</Day><Hour>12</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40591429</ArticleId><ArticleId IdType="pmc">PMC12455745</ArticleId><ArticleId IdType="doi">10.31053/1853.0605.v82.n2.45462</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tjahjono R, Phung D, Gurney H, Riffat F, Palme CE. Thyroid gland metastasis from renal cell carcinoma: a case series and literature review . ANZ J Surg. 2021;91:708&#x2013;715. doi: 10.1111/ans.16482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ans.16482</ArticleId><ArticleId IdType="pubmed">33319504</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel U, Sokhi H. Imaging in the follow-up of renal cell carcinoma. AJR Am J Roentgenol . 2012;198:1266&#x2013;1276. doi: 10.2214/AJR.11.8381.</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/AJR.11.8381</ArticleId><ArticleId IdType="pubmed">22623538</ArticleId></ArticleIdList></Reference><Reference><Citation>Madore P, Lan S. Solitary thyroid metastasis from clear-cell renal carcinoma. Can Med Assoc J . 1975;112:719, 721.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1956189</ArticleId><ArticleId IdType="pubmed">1122443</ArticleId></ArticleIdList></Reference><Reference><Citation>Moraes PH de M, Sigrist R, Takahashi MS, Chammas MC. Ultrasound elastography in the evaluation of thyroid nodules: evolution of a promising diagnostic tool for predicting the risk of malignancy . Radiol Bras. 2019;52:247&#x2013;253. doi: 10.1590/0100-3984.2018.0084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0100-3984.2018.0084</ArticleId><ArticleId IdType="pmc">PMC6696751</ArticleId><ArticleId IdType="pubmed">31435087</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen M, He G, Lam AK-Y. Clinicopathological and Molecular Features of Secondary Cancer (Metastasis) to the Thyroid and Advances in Management . Int J Mol Sci. 2022;23 doi: 10.3390/ijms23063242.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23063242</ArticleId><ArticleId IdType="pmc">PMC8955551</ArticleId><ArticleId IdType="pubmed">35328664</ArticleId></ArticleIdList></Reference><Reference><Citation>Nixon IJ, Coca-Pelaz A, Kaleva AI, Angelos P, Owen RP, Rinaldo A, Shaha AR, Silver CE, Ferlito A. Metastasis to the Thyroid Gland: A Critical Review. Ann Surg Oncol. 2017;24:1533&#x2013;1539. doi: 10.1245/s10434-016-5683-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-016-5683-4</ArticleId><ArticleId IdType="pmc">PMC5413529</ArticleId><ArticleId IdType="pubmed">27873099</ArticleId></ArticleIdList></Reference><Reference><Citation>Song OK, Koo JS, Kwak JY, Yoon JH, Kim E-K. Metastatic renal cell carcinoma in the thyroid gland: ultrasonographic features and the diagnostic role of core needle biopsy . Ultrasonography. 2017;36:252&#x2013;259. doi: 10.14366/usg.16037.</Citation><ArticleIdList><ArticleId IdType="doi">10.14366/usg.16037</ArticleId><ArticleId IdType="pmc">PMC5494867</ArticleId><ArticleId IdType="pubmed">27956733</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamczewski Z, Dedecjus M, Skowro&#x144;ska-J&#xf3;&#x17a;wiak E, Lewi&#x144;ski A. Metastases of renal clear&#x2011;cell carcinoma to the thyroid: a comparison of shear&#x2011;wave and quasi&#x2011;static elastography . Pol Arch Med Wewn. 2014;124:485&#x2013;486. doi: 10.20452/pamw.2413.</Citation><ArticleIdList><ArticleId IdType="doi">10.20452/pamw.2413</ArticleId><ArticleId IdType="pubmed">24995474</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrioli M, Persani L. Elastographic presentation of synchronous renal cell carcinoma metastasis to the thyroid gland . Endocrine. 2014;47:336&#x2013;337. doi: 10.1007/s12020-013-0124-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-013-0124-7</ArticleId><ArticleId IdType="pubmed">24366638</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadarola C, Croce L, Quaquarini E, Pinto S, Bernardo A, Fonte R, Marin&#xf2; M, Rotondi M, Chiovato L. Nivolumab Induced Thyroid Dysfunction: Unusual Clinical Presentation and Challenging Diagnosis . Front Endocrinol (Lausanne) 2019. Jan, 17;9:813.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2018.00813</ArticleId><ArticleId IdType="pmc">PMC6345097</ArticleId><ArticleId IdType="pubmed">30705667</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadieh H, Salti I. Tyrosine kinase inhibitors induced thyroid dysfunction: a review of its incidence, pathophysiology, clinical relevance, and treatment . Biomed Res Int. 2013;2013:725410. doi: 10.1155/2013/725410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/725410</ArticleId><ArticleId IdType="pmc">PMC3824811</ArticleId><ArticleId IdType="pubmed">24282820</ArticleId></ArticleIdList></Reference><Reference><Citation>Beutner U, Leowardi C, Bork U, Tarantino I, Pahernik S, et al. Survival after renal cell carcinoma metastasis to the thyroid: single center experience and systematic review of the literature . Thyroid. 2015;25:314&#x2013;324. doi: 10.1089/thy.2014.0498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/thy.2014.0498</ArticleId><ArticleId IdType="pubmed">25491306</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30250323</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>26</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0016-3813</ISSN><JournalIssue CitedMedium="Print"><Volume>154</Volume><Issue>4</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Gaceta medica de Mexico</Title><ISOAbbreviation>Gac Med Mex</ISOAbbreviation></Journal><ArticleTitle>Evaluaci&#xf3;n cl&#xed;nica y ultrasonogr&#xe1;fica de la gl&#xe1;ndula tiroides en pacientes con artritis reumatoide.</ArticleTitle><Pagination><StartPage>432</StartPage><EndPage>437</EndPage><MedlinePgn>432-437</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.24875/GMM.18003556</ELocationID><Abstract><AbstractText Label="INTRODUCCI&#xd3;N">Los pacientes con artritis reumatoide pueden desarrollar enfermedad tiroidea autoinmune (ETA), cuyo diagn&#xf3;stico cl&#xed;nico puede ser dif&#xed;cil debido a que ambas comparten s&#xed;ntomas como artralgias, mialgias, rigidez matutina o fatiga.</AbstractText><AbstractText Label="OBJETIVO">Determinar la prevalencia de ETA en pacientes con artritis reumatoide.</AbstractText><AbstractText Label="M&#xc9;TODO">Estudio transversal que incluy&#xf3; 78 pacientes con artritis reumatoide y 81 controles cl&#xed;nicamente sanos pareados por edad y sexo. A ambos grupos se realiz&#xf3; cuantificaci&#xf3;n de anticuerpos antitiroideos, pruebas de funci&#xf3;n tiroidea, ultrasonido y biopsia de gl&#xe1;ndula tiroides cuando la puntuaci&#xf3;n de Thyroid Imaging Reporting and Data System (TIRADS) fue &#x2265; 4.</AbstractText><AbstractText Label="RESULTADOS">24.4 % de los pacientes con artritis reumatoide present&#xf3; hipotiroidismo (p = 0.003) y altos t&#xed;tulos de anticuerpos antitiroideos versus controles cl&#xed;nicamente sanos; 53 % de los ultrasonidos tiroideos result&#xf3; normal en pacientes hipotiroideos; en pacientes con artritis reumatoide positivos para anticuerpos antitiroideos se encontr&#xf3; perfusi&#xf3;n incrementada en 40 %. Los casos clasificados como TIRADS 4 fueron enviados a aspiraci&#xf3;n, con resultado histopatol&#xf3;gico benigno.</AbstractText><AbstractText Label="CONCLUSIONES">Se demostr&#xf3; el valor cl&#xed;nico agregado de la evaluaci&#xf3;n tiroidea en pacientes con artritis reumatoide, conforme a la prevalencia de hipotiroidismo subcl&#xed;nico, positividad de anticuerpos antitiroideos y anomal&#xed;as en el ultrasonido independientes de la funci&#xf3;n tiroidea normal o alterada.</AbstractText><AbstractText Label="INTRODUCTION">Patients with rheumatoid arthritis can develop autoimmune thyroid disease (ATD), the clinical diagnosis of which can be difficult because both entities share symptoms such as arthralgia, myalgia, morning stiffness or fatigue.</AbstractText><AbstractText Label="OBJECTIVE">To determine the prevalence of ATD in patients with rheumatoid arthritis.</AbstractText><AbstractText Label="METHOD">Cross-sectional study that included 78 patients with rheumatoid arthritis and 81 clinically healthy controls matched by age and gender. Both groups underwent anti-thyroid antibodies quantification, thyroid function tests, thyroid ultrasound and thyroid gland biopsy when the Thyroid Imaging Reporting and Data System (TIRADS) score was &#x2265; 4.</AbstractText><AbstractText Label="RESULTS">Hypothyroidism was found in 24.4% of patients with rheumatoid arthritis (p = 0.003), as well as high titers of anti-thyroid antibodies versus clinically healthy controls; 53% of thyroid ultrasounds were normal in hypothyroid patients, and increased perfusion was found in 40% of rheumatoid arthritis patients who tested positive for anti-thyroid antibodies. Cases classified as TIRADS 4 underwent aspiration with benign histopathological results.</AbstractText><AbstractText Label="CONCLUSIONS">Thyroid assessment added clinical value was demonstrated in patients with rheumatoid arthritis, according to the prevalence of subclinical hypothyroidism, anti-thyroid antibodies positivity and ultrasound abnormalities, regardless of normal or altered thyroid function.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2018 Secretar&#xcd;a de Salud.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Figueroa-S&#xe1;nchez</LastName><ForeName>Mauricio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Civil "Fray Antonio Alcalde", Servicio de Radiolog&#xed;a e Imagen. Jalisco, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>N&#xfa;&#xf1;ez-Atahualpa</LastName><ForeName>Lourdes</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Hospital Civil "Fray Antonio Alcalde", Servicio de Radiolog&#xed;a e Imagen. Jalisco, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez-Z&#xfa;&#xf1;iga</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Civil "Fray Antonio Alcalde", Servicio de Radiolog&#xed;a e Imagen. Jalisco, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;n-Marquez</LastName><ForeName>Beatriz Teresita</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud, Instituto de Investigaci&#xf3;n en Reumatolog&#xed;a y del Sistema M&#xfa;sculo Esquel&#xe9;tico. Jalisco, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez-Garc&#xed;a</LastName><ForeName>Erika Aurora</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud, Instituto de Investigaci&#xf3;n en Reumatolog&#xed;a y del Sistema M&#xfa;sculo Esquel&#xe9;tico. Jalisco, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-Ba&#xf1;uelos</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud, Instituto de Investigaci&#xf3;n en Reumatolog&#xed;a y del Sistema M&#xfa;sculo Esquel&#xe9;tico. Jalisco, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navarro-Hern&#xe1;ndez</LastName><ForeName>Rosa Elena</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud, Instituto de Investigaci&#xf3;n en Reumatolog&#xed;a y del Sistema M&#xfa;sculo Esquel&#xe9;tico. Jalisco, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>V&#xe1;zquez-Del Mercado</LastName><ForeName>M&#xf3;nica</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud, Instituto de Investigaci&#xf3;n en Reumatolog&#xed;a y del Sistema M&#xfa;sculo Esquel&#xe9;tico. Jalisco, M&#xe9;xico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Gac Med Mex</MedlineTA><NlmUniqueID>0010333</NlmUniqueID><ISSNLinking>0016-3813</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007037" MajorTopicYN="N">Hypothyroidism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013960" MajorTopicYN="N">Thyroid Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013967" MajorTopicYN="N">Thyroiditis, Autoimmune</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Artritis reumatoide</Keyword><Keyword MajorTopicYN="N">Hipotiroidismo</Keyword><Keyword MajorTopicYN="N">Hypothyroidism</Keyword><Keyword MajorTopicYN="N">Rheumatoid arthritis</Keyword><Keyword MajorTopicYN="N">TIRADS</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30250323</ArticleId><ArticleId IdType="doi">10.24875/GMM.18003556</ArticleId><ArticleId IdType="pii">j154/4/432</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27445220</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>26</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-8865</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>8</Issue><PubDate><Year>2017</Year><Season>Nov-Dec</Season></PubDate></JournalIssue><Title>Semergen</Title><ISOAbbreviation>Semergen</ISOAbbreviation></Journal><ArticleTitle>[Evaluation of a thyroid disease referral protocal in a health area of Madrid].</ArticleTitle><Pagination><StartPage>569</StartPage><EndPage>573</EndPage><MedlinePgn>569-573</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.semerg.2016.05.010</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1138-3593(16)30100-9</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The collaboration between healthcare levels is essential for our patients. The aim of this study is to determine the suitability of a referral protocol between the different healthcare levels.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A collaboration study was carried out between general practitioners, endocrinologists, and the Department of Biochemistry. After creating the protocol together and implementing it, the suitability was evaluated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 284 referral sheets were evaluated, 65% were adequately sent, and 51% were referred due to laboratory abnormalities, 42% for morphological alterations, and 7% for both reasons. Just under three-quarters (72%) were referred in the normal way (adequacy 90.6%). The clinical information in the referral sheet was considered adequate in 59%, and the request for ultrasound was adequate in 78%. A significant number (16%) of patients should have been returned to Primary Care.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">It is considered that creating protocols is part of our task. The compliance with the protocol can be improved in Primary Care and specialised care.</AbstractText><CopyrightInformation>Publicado por Elsevier Espa&#xf1;a, S.L.U.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>L&#xf3;pez</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro de Salud Panaderas, Fuenlabrada (Madrid), Espa&#xf1;a. Electronic address: aranzazu.lvillal@salud.madrid.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roll&#xe1;n</LastName><ForeName>M T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Centro de Salud Las Rozas El Abaj&#xf3;n, Las Rozas (Madrid), Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bedoya</LastName><ForeName>M J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Centro de Salud Mar&#xed;a Jes&#xfa;s Hereza Cuellar, Legan&#xe9;s (Madrid), Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Servicio de Bioqu&#xed;mica, Hospital Universitario Severo Ochoa, Legan&#xe9;s (Madrid), Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Evaluaci&#xf3;n de un protocolo de derivaci&#xf3;n de enfermedad tiroidea en nuestra &#xe1;rea sanitaria.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2016</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Semergen</MedlineTA><NlmUniqueID>9610769</NlmUniqueID><ISSNLinking>1138-3593</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003299" MajorTopicYN="Y">Cooperative Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058005" MajorTopicYN="N">General Practitioners</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033183" MajorTopicYN="N">Interdisciplinary Communication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012017" MajorTopicYN="N">Referral and Consultation</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013959" MajorTopicYN="N">Thyroid Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Atenci&#xf3;n Primaria</Keyword><Keyword MajorTopicYN="N">Endocrinology</Keyword><Keyword MajorTopicYN="N">Endocrinolog&#xed;a</Keyword><Keyword MajorTopicYN="N">Gl&#xe1;ndula tiroides</Keyword><Keyword MajorTopicYN="N">Primary Care</Keyword><Keyword MajorTopicYN="N">Protocol</Keyword><Keyword MajorTopicYN="N">Protocolo</Keyword><Keyword MajorTopicYN="N">Thyroid</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27445220</ArticleId><ArticleId IdType="doi">10.1016/j.semerg.2016.05.010</ArticleId><ArticleId IdType="pii">S1138-3593(16)30100-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>